UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 126

Sortiert nach

Behçet’s Syndrome and Nervous System Involvement

Current neurology and neuroscience reports, 2018-07, Vol.18 (7), p.35-11, Article 35

2018

Volltextzugriff (PDF)

Nervous system involvement in Behçet's syndrome

Current opinion in rheumatology, 2019-01, Vol.31 (1), p.32

2019

Volltextzugriff (PDF)

Intravenous Methylprednisolone as a Transition Treatment in Red Ear Syndrome: A Case Report

Aǧrı, 2023-10

Kokar, Serdar

2023

Volltextzugriff (PDF)

An unexpected circumstance detected in a patient presenting with radicular low back pain

Aǧrı, 2023-10, p.278-280

Mengi, Alper

2023

Volltextzugriff (PDF)

The diagnostic contribution of intracranial vessel wall imaging in the differentiation of primary angiitis of the central nervous system from other intracranial vasculopathies

Neuroradiology, 2021-10, Vol.63 (10), p.1635-1644

2021

Volltextzugriff (PDF)

Behçet Syndrome

Rheumatic diseases clinics of North America, 2023-08, Vol.49 (3), p.585-602

2023

Volltextzugriff (PDF)

Recurrent tumefactive demyelination under fingolimod treatment

Neurological sciences, 2024-05, Vol.45 (5), p.2377-2378

2024

Volltextzugriff (PDF)

Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markers

PloS one, 2023-06, Vol.18 (6), p.e0287463-e0287463

2023

Volltextzugriff (PDF)

Investigating the role of common and rare variants in multiplex multiple sclerosis families reveals an increased burden of common risk variation

Scientific reports, 2022-10, Vol.12 (1), p.16984-16984, Article 16984

2022

Volltextzugriff (PDF)

Longitudinally extensive transverse myelitis preceding primary central nervous system lymphoma: Spinal sentinel neuroinflammation

The journal of spinal cord medicine, 2023-05, Vol.46 (3), p.521-524

2023

Volltextzugriff (PDF)

Factors Predictive of Severe Multiple Sclerosis Disease Reactivation After Fingolimod Cessation

The Neurologist (Baltimore, Md.), 2018-01, Vol.23 (1), p.12-16

2018

Volltextzugriff (PDF)

Treatment of multiple sclerosis–related trigeminal neuralgia with onabotulinumtoxinA

Headache, 2022-11, Vol.62 (10), p.1322-1328

2022

Volltextzugriff (PDF)

Determinants of glucose metabolism and the role of NPY in the progression of insulin resistance in chronic migraine

Cephalalgia, 2018-10, Vol.38 (11), p.1773-1781

2018

Volltextzugriff (PDF)

Trigeminal neuropathy as presenting symptom of craniofacial venous metameric syndrome

Neurological sciences, 2022-10, Vol.43 (10), p.6155-6157

2022

Volltextzugriff (PDF)

Ocrelizumab in pediatric multiple sclerosis

European journal of paediatric neurology, 2023-03, Vol.43, p.1-5

2023

Volltextzugriff (PDF)

Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome

Multiple sclerosis, 2019-04, Vol.25 (5), p.669-677

2019

Volltextzugriff (PDF)

An uncommon disease included commonly in the differential diagnosis of neurological diseases: Neuro-Behçet's syndrome

Journal of the neurological sciences, 2021-07, Vol.426, p.117436-117436, Article 117436

2021

Volltextzugriff (PDF)

Prominent D‐dimer elevation and pretibial edema related to alemtuzumab treatment: A case report and literature review

Clinical & experimental neuroimmunology, 2022-11, Vol.13 (4), p.208-215

2022

Volltextzugriff (PDF)

Infliximab is a plausible alternative for neurologic complications of Behçet disease

Neurology : neuroimmunology & neuroinflammation, 2016-10, Vol.3 (5), p.e258-e258

2016

Volltextzugriff (PDF)

Recurrent longitudinal extensive transverse myelitis in a neuro-Behçet syndrome treated with infliximab

The journal of spinal cord medicine, 2015-01, Vol.38 (1), p.111-114

2015

Volltextzugriff (PDF)

Analysis of determinants of treatment change in adult paediatric-onset MS patients

Multiple sclerosis and related disorders, 2023-01, Vol.69, p.104463-104463, Article 104463

2023

Volltextzugriff (PDF)

Investigation of multiple sclerosis-related pathways through the integration of genomic and proteomic data

PeerJ (San Francisco, CA), 2021-09, Vol.9, p.e11922, Article e11922

2021

Volltextzugriff (PDF)

Efficacy of Dural Sinus Quantitative Measurements in Idiopathic Intracranial Hypertension: A Practical Diagnostic Feature

Clinical neuroradiology (Munich), 2023-06, Vol.33 (2), p.545-554

2023

Volltextzugriff (PDF)

The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real‐world study from Turkey

International journal of clinical practice (Esher), 2021-07, Vol.75 (7), p.e14158-n/a

2021

Volltextzugriff (PDF)

Brainstem reflexes in neuro-Behçet disease

Neurophysiologie clinique, 2019-11, Vol.49 (5), p.381-384

2019

Volltextzugriff (PDF)

1 – 25 von 126

Suche als RSS-Feed

Aktive Filter

ThemaMigraine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(122)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Behçet’s Syndrome and Nervous System Involvement

Nervous system involvement in Behçet's syndrome

Intravenous Methylprednisolone as a Transition Treatment in Red Ear Syndrome: A Case Report

An unexpected circumstance detected in a patient presenting with radicular low back pain

The diagnostic contribution of intracranial vessel wall imaging in the differentiation of primary angiitis of the central nervous system from other intracranial vasculopathies

Behçet Syndrome

Recurrent tumefactive demyelination under fingolimod treatment

Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markers

Investigating the role of common and rare variants in multiplex multiple sclerosis families reveals an increased burden of common risk variation

Longitudinally extensive transverse myelitis preceding primary central nervous system lymphoma: Spinal sentinel neuroinflammation

Factors Predictive of Severe Multiple Sclerosis Disease Reactivation After Fingolimod Cessation

Treatment of multiple sclerosis–related trigeminal neuralgia with onabotulinumtoxinA

Determinants of glucose metabolism and the role of NPY in the progression of insulin resistance in chronic migraine

Trigeminal neuropathy as presenting symptom of craniofacial venous metameric syndrome

Ocrelizumab in pediatric multiple sclerosis

Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome

An uncommon disease included commonly in the differential diagnosis of neurological diseases: Neuro-Behçet's syndrome

Prominent D‐dimer elevation and pretibial edema related to alemtuzumab treatment: A case report and literature review

Infliximab is a plausible alternative for neurologic complications of Behçet disease

Recurrent longitudinal extensive transverse myelitis in a neuro-Behçet syndrome treated with infliximab

Analysis of determinants of treatment change in adult paediatric-onset MS patients

Investigation of multiple sclerosis-related pathways through the integration of genomic and proteomic data

Efficacy of Dural Sinus Quantitative Measurements in Idiopathic Intracranial Hypertension: A Practical Diagnostic Feature

The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real‐world study from Turkey

Brainstem reflexes in neuro-Behçet disease

Aktive Filter

Suchergebnisse filtern